This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Biotech Stocks Under $10 Making Big Moves

Savient Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Savient Pharmaceuticals ( SVNT) is a biopharmaceutical company with one meaningful drug, Krystexxa, which treats chronic gout refractory to conventional therapy. This stock closed up 6.2% to $0.67 in Tuesday's trading session.

Tuesday's Range: $0.64-$0.68
52-Week Range: $0.51-$2.95
Tuesday's Volume: 743,000
Three-Month Average Volume: 793,930

>>4 Stocks Spiking on Unusual Volume

From a technical perspective, SVNT surged higher here back above its 50-day moving average of 65 cents with decent upside volume. This stock recently formed a double bottom chart pattern at 57 cents to 56 cents per share. Following that bottom, shares of SVNT have started to uptrend and approach a near-term breakout trade. That trade will hit if SVNT manages to take out some near-term overhead resistance at 75 cents with high volume.

Traders should now look for long-biased trades in SVNT as long as it's trending above its 50-day at 65 cents or above more support at 60 cents and then once it sustains a move or close above 75 cents with volume that hits near or above 793,930 shares. If that breakout hits soon, then SVNT will set up to re-test or possibly take out its next major overhead resistance levels at 90 cents to 91 cents per share. Any high-volume move above those levels will then put its 200-day at 94 cents to $1 into range for shares of SVNT.
4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ABIO $4.13 -1.90%
ATHX $2.34 1.30%
TRGT $1.38 -2.13%
SVNT $0.00 0.00%
CRTX $0.00 0.00%


Chart of I:DJI
DOW 17,897.22 +123.58 0.70%
S&P 500 2,080.56 +15.26 0.74%
NASDAQ 4,814.73 +39.3720 0.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs